These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 31269196)
1. Metformin Treatment and Cancer Risk: Cox Regression Analysis, With Time-Dependent Covariates, of 320,000 Persons With Incident Diabetes Mellitus. Dankner R; Agay N; Olmer L; Murad H; Keinan Boker L; Balicer RD; Freedman LS Am J Epidemiol; 2019 Oct; 188(10):1794-1800. PubMed ID: 31269196 [TBL] [Abstract][Full Text] [Related]
2. Metformin Treatment Among Men With Diabetes and the Risk of Prostate Cancer: A Population-Based Historical Cohort Study. Freedman LS; Agay N; Farmer R; Murad H; Olmer L; Dankner R Am J Epidemiol; 2022 Mar; 191(4):626-635. PubMed ID: 34893792 [TBL] [Abstract][Full Text] [Related]
3. Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias. Bowker SL; Lin M; Eurich DT; Johnson JA Can J Diabetes; 2017 Apr; 41(2):204-210. PubMed ID: 27908558 [TBL] [Abstract][Full Text] [Related]
4. Metformin and the risk of prostate cancer across racial/ethnic groups: a population-based cohort study. Chen CB; Eurich DT; Majumdar SR; Johnson JA Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):122-126. PubMed ID: 28071672 [TBL] [Abstract][Full Text] [Related]
5. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK. Kowall B; Stang A; Rathmann W; Kostev K Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313 [TBL] [Abstract][Full Text] [Related]
6. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus. Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195 [TBL] [Abstract][Full Text] [Related]
7. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus. Tseng CH Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464 [TBL] [Abstract][Full Text] [Related]
8. Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus. Kuan YC; Huang KW; Lin CL; Hu CJ; Kao CH Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):77-83. PubMed ID: 28583443 [TBL] [Abstract][Full Text] [Related]
9. Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: An observational population-based study. Vicentini M; Ballotari P; Giorgi Rossi P; Venturelli F; Sacchettini C; Greci M; Mangone L; Pezzarossi A; Manicardi V Diabetes Res Clin Pract; 2018 Sep; 143():398-408. PubMed ID: 29807100 [TBL] [Abstract][Full Text] [Related]
10. Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models. Farmer RE; Ford D; Mathur R; Chaturvedi N; Kaplan R; Smeeth L; Bhaskaran K Int J Epidemiol; 2019 Apr; 48(2):527-537. PubMed ID: 30753459 [TBL] [Abstract][Full Text] [Related]
11. Metformin and other anti-diabetic medication use and breast cancer incidence in the Nurses' Health Studies. Wang T; Chai B; Chen WY; Holmes MD; Erdrich J; Hu FB; Rosner BA; Tamimi RM; Willett WC; Kang JH; Eliassen AH Int J Cancer; 2024 Jul; 155(2):211-225. PubMed ID: 38520039 [TBL] [Abstract][Full Text] [Related]
12. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus. Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378 [TBL] [Abstract][Full Text] [Related]
13. Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial. Tsilidis KK; Capothanassi D; Allen NE; Rizos EC; Lopez DS; van Veldhoven K; Sacerdote C; Ashby D; Vineis P; Tzoulaki I; Ioannidis JP Diabetes Care; 2014 Sep; 37(9):2522-32. PubMed ID: 24898303 [TBL] [Abstract][Full Text] [Related]
14. Use of metformin and risk of kidney cancer in patients with type 2 diabetes. Tseng CH Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530 [TBL] [Abstract][Full Text] [Related]
15. Metformin use and lung cancer risk in patients with diabetes. Sakoda LC; Ferrara A; Achacoso NS; Peng T; Ehrlich SF; Quesenberry CP; Habel LA Cancer Prev Res (Phila); 2015 Feb; 8(2):174-9. PubMed ID: 25644512 [TBL] [Abstract][Full Text] [Related]
16. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon Cancer in Patients With Type 2 Diabetes. Erkinantti S; Marttila M; Sund R; Arffman M; Urpilainen E; Puistola U; Hautakoski A; Karihtala P; Läärä E; Jukkola A Clin Colorectal Cancer; 2021 Jun; 20(2):e113-e119. PubMed ID: 33279415 [TBL] [Abstract][Full Text] [Related]
17. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes. Tseng CH Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842 [TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523 [TBL] [Abstract][Full Text] [Related]
19. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study. Calip GS; Yu O; Elmore JG; Boudreau DM Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250 [TBL] [Abstract][Full Text] [Related]
20. Metformin and lung cancer risk in patients with type 2 diabetes mellitus. Tseng CH Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]